NEW YORK (GenomeWeb News) — Innogenetics today said that a US District Court in Wisconsin has barred Abbott Laboratories from using or selling its hepatitis C genotyping technology anywhere in the world after an earlier verdict found Abbott to infringe a US patent held by Innogenetics.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.